Glypican-6 promotes the growth of developing long bones by stimulating Hedgehog signaling. by Capurro, M. et al.
JCB
JCB: Article
T
H
E
 J
O
U
R
N
A
L
 O
F
 C
E
L
L
 B
IO
L
O
G
Y
2911
The Rockefeller University Press 
J. Cell Biol. Vol. 216 No. 9 2911–2926
https://doi.org/10.1083/jcb.201605119
Introduction
Autosomal-recessive omodysplasia (OMOD1) is a skeletal dys-
plasia characterized by short stature, severely shortened limbs, 
and craniofacial dysmorphisms (Borochowitz et al., 1998; 
Elçioglu et al., 2004). Other variable abnormalities include 
cryptorchidism, hernias, congenital heart defects, and cog-
nitive delay (Borochowitz et al., 1998; Elçioglu et al., 2004). 
OMOD1 was first described in 1989, and its incidence is still 
unknown. This genetic condition is caused by loss-of-function 
mutations of glypican 6 (GPC6; Campos-Xavier et al., 2009). 
Consistent with this finding, GPC6 is expressed in the prolifer-
ative zone of the mouse bone growth plate (Ahrens et al., 2009; 
Campos- Xavier et al., 2009).
GPCs are a family of proteoglycans that are linked to 
the plasma membrane through a glycosylphosphatidylinositol 
anchor. Six members of the GPC family have been identified 
in mammals (GPC1 to GPC6; Filmus et al., 2008; Filmus and 
Capurro, 2012). Structural features that are conserved across 
the family include the localization of 14 cysteine residues and 
of the domain in which the glycosaminoglycan (GAG) chains 
are inserted. This domain is located close to the C terminus, 
placing the GAG chains in proximity to the cell surface (Filmus 
et al., 2008). GPCs display several GAG attachment sites (from 
two in GPC3 to four in GPC5 and GPC6). The functional im-
plications of the variation in the number of GAG chains are 
still unknown. Most GPCs have been shown to only carry hep-
aran sulfate (HS) chains. Another remarkable feature of GPCs 
is that they do not display domains with obvious homology to 
characterized domains found in other proteins, suggesting that 
GPCs have unique functions.
GPCs regulate the signaling activity of various morpho-
gens/growth factors, including Hedgehogs (Hhs; Desbordes and 
Sanson, 2003; Lum et al., 2003; Wilson and Stoeckli, 2013), 
FGFs (Hagihara et al., 2000; Yan and Lin, 2007), Wnts (Oh-
kawara et al., 2003; Song et al., 2005), and bone morphoge-
netic proteins (Jackson et al., 1997; Akiyama et al., 2008; 
Taneja-Bageshwar and Gumienny, 2013). In most cases, this 
regulatory activity is based on the ability of GPCs to either in-
hibit or stimulate the interaction of these growth factors with 
their signaling receptors. It is now well established that the 
structural features of GPCs combine with the set of growth fac-
tors and growth factor receptors present in a given cell type to 
determine GPC function.
Hhs are growth factors/morphogens that play a critical 
role in tissue patterning during embryonic development and 
in the preservation of homeostasis in the adult (Robbins et al., 
2012; Briscoe and Thérond, 2013; Lee et al., 2016). Three Hhs 
have been identified in mammals: Sonic Hh (Shh), Indian Hh 
(Ihh), and Desert Hh. Whereas Shh is produced by many tissues, 
the expression of Ihh and Desert Hh is restricted to a few cell 
types. Ihh is the only Hh found in developing bone (St-Jacques 
et al., 1999). The main cell membrane receptor of Hh is Patched 
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1 (Ptc1), a 12-span transmembrane protein. In the absence of 
Hh, Ptc1 suppresses the activity of Smoothened (Smo), another 
transmembrane protein. Hh stimulation abrogates the inhibition 
of Smo by Ptc1. Then, activated Smo triggers a signaling cas-
cade that induces target gene transcription through the Gli fam-
ily of transcription factors (Ryan and Chiang, 2012; Briscoe and 
Thérond, 2013). Although the target genes that are regulated 
by Hh signaling are cell-type specific, in general this signaling 
pathway activates the expression of genes that play a critical 
role in the cell cycle (i.e., cyclin D1; Oliver et al., 2003) and in 
the regulation of cell survival (i.e., Bcl-2; Bar et al., 2007). In 
addition, the list of target genes includes several components 
of the Hh pathway, such as Gli1 and Ptc1, indicating the exis-
tence of feed-back loops. Consistent with the crucial role that 
Hhs play in tissue patterning during embryonic development, 
mutations of several components of the Hh signaling pathway 
cause various congenital diseases, including holoprosenceph-
aly, brachydactyly, and several bone dysplasias (Zhang et al., 
2006; Gao et al., 2009). In vertebrates, Hh binds to Ptc1 at the 
primary cilium (Rohatgi et al., 2007). Hh cannot activate sig-
naling activity in cells without this appendage (Toftgård, 2009).
The long bones are formed during development by a pro-
cess called endochondral ossification, which starts in the growth 
plates located at the ends of the bones. The zone of the growth 
plate furthest from the ossification front is populated by resting 
chondrocytes (Mackie et al., 2008). Next to the resting zone 
is the proliferative zone, which contains cells that are actively 
proliferating, display a flattened shape, and are packed in clus-
ters. Proliferating chondrocytes then mature into quiescent and 
enlarged prehypertrophic chondrocytes. Moving toward the os-
sification front, these cells become hypertrophic chondrocytes, 
which produce and deposit an extracellular matrix that becomes 
invaded by blood vessels and precursors of osteoblasts (Mackie 
et al., 2008; Karsenty et al., 2009).
Ihh, which is produced by the prehypertrophic cells (St-
Jacques et al., 1999; Long et al., 2001), stimulates cell-cycle 
progression in the proliferative cells of the growth plate, which 
express Ptc1 (Long et al., 2001). The key role of Ihh in bone 
growth is underscored by the striking phenotype of the Ihh-null 
mice, where all skeletal structures are substantially reduced in 
size (St-Jacques et al., 1999).
The ability of GPCs to regulate Hh signaling was first 
reported in Drosophila (Lum et al., 2003). In mammals, GPCs 
can act as stimulators or inhibitors of Hh signaling (Filmus and 
Capurro, 2014). GPC5 and GPC1 have been shown to act as posi-
tive regulators of Hh activity (Li et al., 2011; Wilson and Stoeckli, 
2013; Witt et al., 2013). GPC3, however, acts as an Hh inhibitor 
(Capurro et al., 2008). We have shown that GPC5 promotes the 
binding of Hh to Ptc1, and we have proposed that this stimulatory 
activity is because of the fact that GPC5 can bind to both Hh and 
Ptc1 (Li et al., 2011). Conversely, GPC3 binds with high affinity 
to Hh, but it does not interact with Ptc1 (Capurro et al., 2008). 
The binding of Hh to GPC3 triggers the endocytosis and deg-
radation of the GPC3/Hh complex (Capurro et al., 2008). Thus, 
GPC3 acts as a signaling inhibitor by competing with Ptc1 for 
Hh binding (Capurro et al., 2008). Loss-of-function mutations 
of GPC3 cause Simpson-Golabi-Behmel overgrowth syndrome 
(Pilia et al., 1996). Notably, with regards to long bone length, 
these patients display the opposite phenotype of the OMOD1 pa-
tients, but the role of GPC6 in Hh signaling remains unknown.
Based on the ability of several GPCs to regulate Hh ac-
tivity and on the fact that the Hh signaling pathway plays an 
essential role in promoting the growth of developing bone by 
stimulating chondrocyte proliferation, we have hypothesized 
that GPC6 is required for optimal Hh activity in the developing 
bone and that OMOD1 is caused, at least in part, by reduced Hh 
activity caused by the lack of GPC6. Here, we present genetic 
and biochemical evidence to support this hypothesis. In addi-
tion, we describe critical features of the mechanism by which 
GPC6 stimulates Hh activity.
Results
Characterization of GPC6-null embryos
The generation of GPC6-null mice has been previously re-
ported (Tang et al., 2010). The only information provided by the 
study was that the GPC6-null mice display embryonic lethality. 
By breeding GPC6 heterozygous mice, we have established 
that mice lacking GPC6 die at birth, as we found the expected 
Mendelian frequency of knockout (KO) embryos at E17.5–18.5 
(Table 1), but we did not identify any live newborn KO mice.
Compared with the WT littermates, E17.5–18.5 GPC6-null 
embryos are significantly lighter (Fig. 1 A). In contrast, GPC6 
heterozygous and WT embryos have similar weight. Staining of 
E17.5 embryos with Alcian blue/Alizarin red revealed that the 
long bones of the GPC6-null embryos are shorter than those of 
the WT littermates (Figs. 1 B and 2 B). In addition, the presence 
of red staining indicates that, unlike in the Ihh-null mice (St-
Jacques et al., 1999), the bones in the GPC6 KOs undergo dif-
ferentiation/ossification. This is consistent with the observation 
that GPC6 is not expressed in the perichondrium, which plays 
a critical role in ossification, a process that is regulated by Ihh 
(Long et al., 2001). The cells from the perichondrium differ-
entiate into osteoblasts, which produce the mineralized matrix 
required for bone formation. Notably, the long bone phenotype 
of the GPC6-null mice at the macroscopic level seems to be 
similar to that of the cartilage-specific Smo-KO mice. In these 
mice, the Hh pathway has been inactivated in the growth plate, 
but it is still active in the perichondrium (Long et al., 2001). The 
Alcian blue/Alizarin red staining of the embryos also revealed 
that the GPC6-null mice display a smaller skull and muzzle and 
a normal spine (Fig. 1 B).
Next, we measured the length of the femurs at E17.5 and 
E15.5. We found that these bones are significantly shorter in the 
GPC6-null embryos (Fig. 2 A). We also compared the length of 
the bones from the upper limbs. In all cases, the bones from the 
GPC6-null embryos were significantly shorter than those from 
WT embryos (Fig. 2 B). In fact, compared with the difference 
observed in body weight, the limbs of the GPC6-null mice were 
disproportionally smaller. These results are consistent with the 
Table 1. Generation of GPC6-null mice
Genotype Number of mice Expected frequen-
cy (%)
Observed fre-
quency (%)
WT 38 25 21.5
Heterozygote 91 50 51.4
KO 48 25 27.1
Breeding data (female Gpc6+/− × male Gpc6+/−) corresponding to 23 litters. A total 
of 177 embryos were collected at E17.5–E18.5.
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phenotype of OMOD1 patients. Tissue sections of the femurs 
were prepared, stained with toluidine blue, and examined under 
a microscope. We found that the chondrocytes in the prolif-
erative zone of the growth plate were disorganized, and they 
lacked the typical cell stacking in columns (Fig. 2 C). This phe-
notype had 100% penetrance. A similar disorganization of the 
growth plate has been reported in the Ihh-null mice (Koziel et 
al., 2005). We also compared the length of the diaphysis portion 
of E17.5 femurs, tibias, and fibulas. We found that the reduction 
in the length of the diaphysis of the GPC6-null embryos was 
even more pronounced than that of the whole bones (Fig. 2 D).
Another noticeable anatomical difference between the 
GPC6-null mice and the normal littermates was the size of the 
skull, which was significantly smaller in the KOs (Fig. 2 E). 
We also found that the GPC6-null mice display cleft pal-
ate (Fig.  2  F) and nasal septal aplasia (Fig.  2  G) with 100% 
penetrance. The spine and the extremities were normal, as in 
OMOD1 patients. It should be noted that GPC6 plays a role in 
the formation of excitatory synapses (Allen et al., 2012), but 
at this point in time, the cause for the premature death of the 
GPC6-null mice remains unknown.
Evaluation of Hh signaling and cell 
proliferation in femurs of GPC6-
null embryos
To compare the degree of activation of the Hh signaling path-
way in the WT and KO mice, we assessed the levels of Ptc1 
and Gli1 in the embryonic femurs. It is well established that 
Ptc1 and Gli1 are transcriptional targets of the Hh signaling 
pathway (Ingham et al., 2011). Femurs from 15.5-d embryos 
were obtained, and the levels of Ptc1 and Gli1 mRNAs were 
measured by real-time RT-PCR, as previously described 
(Capurro et al., 2008). We found that the levels of Ptc1 and 
Gli1 transcripts are significantly lower in the GPC6-null mice 
compared with normal littermates (Fig. 3 A). From these re-
sults, we conclude that GPC6 stimulates Hh signaling in the 
developing bone. It should be noted that, like the GPC6-null 
mice, the Ihh-null mice also display shorter long bones. How-
ever, the long bone phenotype of the Ihh-null mice is more 
severe than that of the GPC6 mutants. This is probably be-
cause of the fact that GPC6 stimulates Hh signaling, but it is 
not essential for Hh activity. In addition, unlike GPC6, the Ihh 
signaling receptor Ptc1 is expressed in the perichondrium (St-
Jacques et al., 1999). Thus, in addition to displaying reduced 
chondrocyte proliferation, Ihh-null mice exhibit deficient os-
teoblast development (St-Jacques et al., 1999).
HS proteoglycans can play a role in the secretion of Hh 
(Hilton et al., 2005; Bandari et al., 2015). Thus, it could be hy-
pothesized that the bone phenotype of the GPC6-null mice is 
caused by changes in the levels and/or extracellular distribu-
tion of Ihh. However, immunostaining and Western blot analy-
sis of the femur growth plate showed that the expression levels 
and distribution of Ihh in the GPC6-null E17.5 embryos were 
similar to those of WT littermates (Fig. 3 B and Fig. S1). This 
is consistent with the fact that GPC6 is not expressed in the 
prehypertrophic zone, which is the area where Ihh is secreted 
(Campos-Xavier et al., 2009).
Ihh is a strong stimulator of chondrocyte proliferation 
during long bone development (Long et al., 2001). Based 
on this, we hypothesized that chondrocytes from the growth 
plates of GPC6-null mice should display reduced prolifera-
tion. To test this hypothesis, we compared the BrdU label-
ing index in growth plate sections of femurs from mutant 
mice and normal littermates. As shown in Fig. 3 C, we found 
that this index is significantly smaller in the GPC6-null 
femurs. We also assessed cell proliferation in the growth 
plate by staining tissue sections with an antibody against 
Ki67. Consistent with the results for the BrdU labeling 
Figure 1. GPC6-null mice display reduced body size and bone abnor-
malities. (A, top) Relative body weights of E17.5–E18.5 embryos of the 
indicated genotype (WT, heterozygous [Het], and KO). The mean WT 
weight in each litter was arbitrarily assigned the value of 1. Bars repre-
sent mean relative weights + SEM. n = 38, 79, and 42 for GPC6 WT, 
heterozygous, and KO, respectively. Statistical analysis was performed by 
Student’s t test (unpaired two-tailed). (Bottom) Scatter plot representation 
of the data. (B) Alcian blue–Alizarin red staining of E17.5 embryos of 
the indicated genotypes.
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Figure 2. GPC6-null mice display shorter long bones and face dysmorphisms. (A) Whole femurs were dissected from E17.5 or E15.5 embryos of the 
indicated genotypes. Images were acquired with a camera (DFC 295; Leica) using a stereoscope (M60; Leica), and femur length was measured using 
the Leica Application Suite (V3.8). Scatter plots with the mean ± SEM of eight WT and seven KO embryos are shown. Mean WT femur length in each 
litter was arbitrarily assigned the value of 1. (B, top) Upper limbs were dissected from GPC6 WT and GPC6 KO E18.5 embryos and stained with Alcian 
blue–Alizarin red. Images were acquired with a camera (DFC 295) using a stereoscope (M60). Representative bones are shown. (Bottom) Images from 
three WT and three KO femurs from different litters were measured with the Leica Application Suite (V3.8). The graph shows scatter plots with the mean 
± SEM. (C) Proximal femoral metaphysis from E17.5 embryos of the indicated genotypes were stained with hematoxylin/eosin, and pictures were taken 
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index, we found that the growth plates of the GPC6-null 
femurs display a relative significantly lower percentage of 
Ki67-positive cells (Fig. 3 D).
In addition to showing a reduced BrdU index, the chon-
drocytes from the Ihh null also display lower levels of cyclin 
D1, an Hh signaling target gene whose expression is regulated 
by mitogens (Long et al., 2001). Therefore, we assessed the rel-
ative cyclin D1 levels in growth plate sections of femurs derived 
from GPC6-null embryos and normal littermates by immunos-
taining with an anti–cyclin D1 antibody. As expected, cyclin 
D1 levels were found to be significantly reduced in the mutant 
growth plates (Fig. 3 E).
We have previously generated genetic evidence demon-
strating that the Hh pathway mediates the growth-inhibitory 
effect of GPC3 by breeding GPC3 heterozygous and Ihh het-
erozygous mice (Capurro et al., 2009). Following a similar 
approach, we tested the hypothesis that the GPC6-induced 
stimulation of chondrocyte proliferation in the developing 
bone is mediated, at least in part, by the Hh signaling path-
way. To this end, first, GPC6 and Ihh heterozygous mice were 
bred to generate double heterozygotes. It should be noted 
that GPC6 heterozygous (Fig.  1  A) and Ihh heterozygous 
mice (Long et al., 2006) display normal size and that Ihh KO 
mice are significantly smaller than normal mice (St-Jacques 
et al., 1999). Next, the double-heterozygous mice were bred, 
and every E17.5 embryo from each litter generated by the 
breeding was genotyped and weighted. In addition, we dis-
sected the femurs of some of them, and bone length was 
measured. If, according to our hypothesis, GPC6 regulates 
long bone growth by stimulating Ihh pathway, it would be 
expected that GPC6/Ihh double heterozygotes would be 
smaller and display shorter long bones than GPC6 or Ihh 
single heterozygotes, that the GPC6 KO/Ihh heterozygotes 
would be smaller and display shorter long bones than the 
GPC6 KO/Ihh WT, and that the double-KO embryos would 
neither be smaller nor display shorter long bones than the Ihh 
KO/GPC6 WT embryos. However, if GPC6 regulates long 
bone growth independently of the Ihh pathway, it will be 
expected that the double-KO embryos will display a larger 
reduction in body weight and length of the long bones than 
that observed in each single KO.
The results shown in Fig.  4 are consistent with our 
hypothesis, as the double-heterozygous embryos are sig-
nificantly smaller (Fig.  4  A) and display shorter femurs 
(Fig.  4  B) than the normal littermates, and the GPC6 KO/
Ihh heterozygous embryos are significantly smaller and dis-
play shorter femurs than the GPC6 KO/Ihh WT. Further-
more, the double-KO embryos and the GPC6 heterozygous/
Ihh KO embryos have similar weights and femur lengths 
as the GPC6 WT/Ihh KO embryos (Fig. 4, A and B). Thus, 
these results provide strong genetic support for the hypoth-
esis that the Ihh pathway mediates the growth-stimulatory 
effect of GPC6 in the bones.
Characterization of chondrocyte-specific 
GPC6-null mice
To completely rule out the possibility that the bone phenotype 
observed in the GPC6-null mice is caused, at least in part, by 
an indirect effect of the lack of GPC6 in other tissues/organs 
during development, chondrocyte-specific GPC6-null mice 
were generated. To this end, we crossed a mouse strain carry-
ing a floxed allele of GPC6 with a strain carrying a Cre gene 
under the transcriptional control of the Col2α1 promoter. This 
approach has been previously used to generate chondrocyte- 
specific Ihh-null and Smo-null strains (Long et al., 2001; Raz-
zaque et al., 2005). Mice carrying the chondrocyte-specific 
GPC6 deletion (Col2α1Cre; GPC6d/GPC6d) were born at the 
expected Mendelian frequency. Shortening of the long bones in 
newborn mutants was mild. However, by P15, a substantial dif-
ference in the length of the WT and mutant long bones was evi-
dent. Then, P21 mice were sacrificed, and femurs and tibia were 
dissected, and their lengths were measured. As shown in Fig. 5, 
these measurements confirmed that the Col2α1Cre;GPC6d/ 
GPC6d mice display long bones that are significantly shorter 
than their normal littermates (Fig. 5). By performing real time 
RT-PCR, we verified that GPC6 expression was dramatically 
reduced in the mutant strain (Fig. 5). Tissue sections of the mu-
tated growth plates were stained with toluidine blue and exam-
ined under the microscope. Similar to what was observed in the 
global GPC6-null strain, the proliferative zones in the growth 
plates of the tissue-specific mutants displayed a disorganized 
structure. Obvious facial dysmorphism was also observed (not 
depicted). Most likely, the delay in the manifestation of the 
bone phenotype in the chondrocyte-specific mutants compared 
with the global mutants is because of an incomplete and/or de-
layed deletion of the floxed GPC6.
Effect of GPC6 on Hh signaling
To investigate the mechanism by which GPC6 stimulates Hh 
signaling, we first tested the effect of GPC6 on Hh activity in 
NIH 3T3 cells by performing a luciferase reporter assay, in 
which luciferase expression was driven by an Hh-responsive 
promoter. As shown in Fig. 6 A and Fig. S2, this assay revealed 
that GPC6 strongly stimulates ShhN (Shh N-terminal domain) 
and fully mature Shh activity in a dose-dependent manner. As 
a control, we showed that, in the same assay, GPC3 displays 
an Hh-inhibitory activity (Fig. 6 A), as we and others have pre-
viously reported (Capurro et al., 2008; Williams et al., 2010). 
Therefore, this result provides additional evidence indicating 
that GPC6 stimulates Hh signaling.
Next, we sought to uncover the mechanism by which 
GPC6 stimulates Hh signaling. We have previously demon-
strated that GPC5 increases Shh activity by promoting the 
binding of Shh to Ptc1 (Li et al., 2011). Therefore, we decided 
to investigate the effect of GPC6 on the interaction of these 
two proteins. To this end, we followed the same experimental 
design as the one we used to study the effect of GPC5 on the 
under the microscope. Insets represent an eight-times enlargement of the low-power picture. Bars, 100 µm. (D) The indicated bones were dissected from 
GPC6 WT (n = 6) and GPC6 KO (n = 6) E18.5 embryos and stained with Alcian blue–Alizarin red. Images were acquired, and the lengths of the diaphysis 
were measured as in B. The graph show scatter plots with the mean ± SEM. Mean WT bone length in each litter was arbitrarily assigned the value of 1.  
(E, left) Representative sagittal head sections corresponding to E18.5 GPC6 WT and GPC6 KO embryos. (Right) Skull length from the base of the skull to 
the end of nasal plenum was measured in GPC6 WT (n = 6) and KO (n = 6) embryos. Results are shown as a scatter plot with the mean ± SEM. Mean WT 
skull length in each litter was arbitrarily assigned the value of 1. (F and G) Representative cross-sections of the skulls of E18.5 embryos of the indicated 
genotypes illustrating the palatoschisis (arrow and circle; F) and nasal septal aplasia (circles; G) observed in the GPC6-null mice with a 100% penetrance 
(n = 5 of each genotype). Statistical analysis was performed by Student’s t tests (unpaired two-tailed).
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interaction of Shh and Ptc1 (Li et al., 2011). NIH 3T3 cells 
were transfected with different amounts of GPC6, and 2 d after 
transfection, the cells were incubated with Shh-AP fusion pro-
tein. Then, cells were lysed, Ptc1 was immunoprecipitated, 
and the levels of Shh-AP that coimmunoprecipitated with Ptc1 
were measured. As shown in Fig. 6 B, we found that GPC6 
significantly stimulates the binding of Shh to Ptc1 in a dose- 
dependent manner. It should be noted that, in this experimental 
protocol, the effect of GPC6 is most likely underestimated, as 
only a proportion (15–20%) of the cells uptake the transfected 
GPC6 cDNA, whereas Ptc1 is being immunoprecipitated from 
all the cells in the plate. As a control, we performed in parallel 
a similar experiment with GPC3. As previously reported, we 
observed that this GPC inhibits the interaction of Shh with Ptc1 
(Capurro et al., 2008).
GAG chains are required for GPC5-induced stimulation 
of Hh signaling in NIH3T3 cells (Li et al., 2011). Therefore, 
we investigated whether the GAG chains are also required for 
Figure 3. GPC6-null femurs display reduced Hh signaling and chondrocyte proliferation. (A) Comparison of the levels of Ptc1 and Gli1 in E15.5 femurs. 
Ptc1 and Gli1 transcripts were measured by real-time RT-PCR using β-actin transcript levels as references. A total of six GPC6 WT and six GPC6-null (KO) 
femurs dissected from four litters of E15.5 embryos were analyzed. Mean WT value for each litter was arbitrarily considered as 1, and the relative levels 
of expression of the KOs were calculated. Scatter plots show the mean + SEM. (B) Immunohistochemical analysis of Ihh in E15.5 femur sections. Staining 
was performed in three littermate pairs of KO and WT embryos and one pair of KO and heterozygous embryos from three different litters. A representative 
result is shown. Bars, 100 µm. (C) BrdU labeling index of growth plates from femur sections dissected from E15.5 embryos. The results represent the mean 
+ SEM of pairs of WT and KO mice from three different litters. The mean percentage of WT sections was defined as 1. All the nuclei in each femur section 
were counted (from 370 to 650 nuclei). Scatter plots show the mean ± SEM. (D) Immunohistochemical analysis of Ki67 in E15.5 femur growth plate sec-
tions. The percentage of positive cells was calculated. The results represent the mean ± SEM of pairs of WT and KO mice from three different litters. All the 
nuclei in each femur section were counted (from 370 to 650 nuclei). The mean percentage of WT sections was defined as 1. Scatter plots show the mean ± 
SEM. (E) Immunohistochemical analysis of cyclin D1 in E15.5 femur growth plate sections. Staining was performed in three pairs of KO and WT embryos 
from three different litters. (Left) A representative result is shown. Bars, 50 µm. (Right) Percentage of positive cells was calculated. The results represent the 
mean ± SEM of pairs of WT and KO mice from three different litters. All the nuclei in each femur section were counted (from 370 to 650 nuclei). The mean 
percentage of WT sections was defined as 1. Statistical analysis was performed by Student’s t test (unpaired two-tailed).
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GPC6-induced stimulation of Hh signaling. To this end, we 
generated a GPC6 mutant where the four attachment sites for 
the GAG chains have been mutated (GPC6ΔGAG) and tested 
the effect of this mutant on the Hh luciferase reporter assay in 
NIH 3T3 cells. We found that the nonglycanated GPC6 had a 
small stimulatory effect on Hh signaling that could only be seen 
when large amounts of this mutant were transfected (Fig. 6 C). 
This result suggests that the GAG chains play a key role in 
GPC6 activity. In addition, this result indicates that the mech-
anism by which GPC6 stimulates Hh signaling is somewhat 
different than that of GPC5, as the Hh-stimulatory activity of 
GPC5 was completely abrogated in the absence of the GAG 
chains (Li et al., 2011).
Analysis of the interaction of GPC6 with 
Shh, Ihh, and Ptc1
Next, we investigated the mechanism by which GPC6 stimu-
lates the binding of Hh to Ptc1. We hypothesized that GPC6 can 
facilitate/stabilize the interaction of Hh with Ptc1. If this hy-
pothesis were correct, it would be expected that GPC6 interacts 
with both Hh and Ptc1. First, we investigated whether GPC6 in-
teracts with Shh by surface plasmon resonance (SPR) analysis. 
A GPC6-AP fusion protein (GPC6-AP) was purified from 293T 
cells and immobilized onto a sensor chip to measure its binding 
to recombinant Shh and Ihh. GPC6-AP was shown to bind to 
Shh and Ihh with comparable nanomolar dissociation constants 
(KD’s; 12 ± 3 nM and 14 ± 2 nM, respectively; Fig. 7 A). We 
also investigated the role of the core protein in the GPC6/Hh 
interaction. To this end, we performed SPR analysis with the 
nonglycanated GPC6ΔGAG mutant. We found that both Shh 
and Ihh bind to this mutant with relatively similar affinity to 
that observed for the glycanated GPC6 (KD of 21 ± 2 nM for 
Shh and 16 ± 4 nM for Ihh; Fig. 7 A), indicating that the GPC6 
core protein is the main mediator of the GPC6/Hh interaction. 
However, these results do not exclude the possibility that the 
GAG chains of GPC6 also interact with Shh and Ihh.
In light of the fact that Ptc1 could not be purified, we per-
formed a pull-down assay to investigate the interaction of GPC6 
and the GPC6ΔGAG mutant with Ptc1. We have previously used 
this approach to assess the interaction of GPC3 and GPC5 with 
Ptc1 (Capurro et al., 2008; Li et al., 2011). 293T cells were tran-
siently transfected with an expression vector for hemagglutinin 
A (HA)–tagged Ptc1, and cell lysates were subsequently mixed 
with beads covered with an anti-HA antibody. Then, the beads 
were incubated with conditioned media containing equal con-
centrations of a GPC6-AP fusion protein or a GPC6ΔGAG-AP 
fusion protein. After washing, the amount of AP enzymatic ac-
tivity that remained bound to the beads was measured. We found 
that, whereas there was a significant binding of WT GPC6, the 
GPC6ΔGAG mutant did not show any detectable binding 
(Fig. 7 B). This result indicates that GPC6 interacts directly or 
indirectly with Ptc1 through the GAG chains.
As an additional approach to assess the GPC6/Ptc1 inter-
action, we performed a cell-binding assay. To this end, 293T 
cells were transfected with Ptc1 or control vector and incu-
bated with a GPC6-AP fusion protein or a GPC6ΔGAG-AP 
fusion protein for 2 h. After extensive washing, the cells were 
lysed, and AP activity that remained bound to the cell lysates 
was measured. Consistent with the pull-down assay results, we 
found significant binding of the WT GPC6 to the Ptc1-trans-
fected cells. The binding was drastically reduced for the nong-
lycanated mutant (Fig. 7 C).
Localization of GPC6
It is now well established that Hh signaling is triggered at the 
primary cilium and that the interaction between Hh and Ptc1 can 
occur at the ciliary membrane (Rohatgi et al., 2007). Therefore, 
we reasoned that, if GPC6 acts to facilitate and/or stabilize the 
Hh/Ptch1 interaction, this GPC should be found at the ciliary 
membrane. To determine the localization of GPC6, we trans-
fected NIH 3T3 cells with GPC6 or GPC6ΔGAG and stained 
the transfected cells with antibodies against GPC6 and acetyl-
Figure 4. Genetic interaction between GPC6 and the Hh signaling path-
way. (A) GPC6/Ihh double-heterozygous mice were bred, and all E17.5 
embryos from each litter were weighed and genotyped. To be able to 
compare embryos from different litters, the weight of embryos within a 
given litter was normalized by the mean weight of WT embryos, which 
was arbitrarily given a value of 1.  Bars represent the mean weight + 
SEM for the indicated genotypes. The first bar at the right includes mice 
with the three different genotypes that display normal weight: GPC6+/+ 
Ihh+/+, GPC6+/− Ihh+/+, and GPC6+/+ Ihh+/−. Numbers on the bars rep-
resent the number of embryos that were weighted for each genotype. 
(B) Femurs from some of the litters generated by breeding the GPC6/Ihh 
double-heterozygous mice were dissected, and their length was mea-
sured as described in Fig. 2. Scatter plots with the mean ± SEM of the 
indicated number of embryos are shown. Mean WT femur length in each 
litter was arbitrarily assigned the value of 1. Statistical analysis was per-
formed by Student’s t test (unpaired two-tailed).
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ated tubulin, a marker of primary cilium (Fig. 8 A). Surpris-
ingly, we could not detect GPC6 in the cilium. However, when 
the transfected cells were incubated with Shh for 1 h at 37°C, 
most of the GPC6-expressing cells displayed GPC6 in their cilia 
(Fig. 8 A). This result strongly suggests that Shh induces the 
migration of GPC6 to the cilium. In contrast, the GPC6ΔGAG 
mutant did not move into the cilium after incubation with Shh 
(Fig. 8 A). In addition, we noticed that the GPC6 staining in the 
Shh-treated cells was dot like, whereas the staining pattern in 
the untreated cells or in the cells transfected with GPC6ΔGAG 
was more diffuse. Next, we quantified the fluorescence gener-
ated by ciliary GPC6 in cells incubated with Shh for different 
time periods. As shown in Fig. 8 B, we found that GPC6 can be 
detected at the cilia as soon as 30 min after Shh addition and 
that it migrates away from the ciliary membrane very quickly, 
reaching background levels after 4 h. However, GPC6ΔGAG 
was not found in the cilia at any of the investigated time points.
It has been reported that, in the absence of Hh, Ptc1 is 
normally found in the ciliary membrane and that it moves out 
of the cilium upon Shh treatment (Rohatgi et al., 2007). Smo 
displays the opposite behavior (Rohatgi et al., 2007). First, we 
investigated the impact of GPC6 on the Shh-induced migration 
of Smo to the cilium. Transfected cells were stained at different 
time points after the addition of Shh with antibodies for anti–
acetylated tubulin and Smo. We observed that GPC6 stimulated 
the accumulation of Smo in this appendage (Fig. 9 A). These 
changes were not observed when cells were transfected with 
GPC6ΔGAG. We also tried to investigate the effect of GPC6 
on Ptc1 removal from the cilia. However, using commercially 
available antibodies, the detection of Ptc1 was not robust enough 
for accurate quantification.
In principle, the Shh-induced migration of GPC6 to the 
cilium could be a direct consequence of the binding of Shh to 
GPC6, or it could represent an indirect consequence of the ac-
tivation of the Hh signaling pathway. To distinguish between 
these two possibilities, we investigated the impact of treating 
the GPC6-transfected cells with Smo agonist (SAG), a small 
molecule that activates Hh signaling by binding to Smo. As 
shown in Fig. 9 B, we found that SAG treatment failed to induce 
GPC6 migration into the ciliary membrane, suggesting that the 
migration of this GPC to the cilium is a direct consequence of 
its interaction with Shh.
Finally, we examined whether Shh can induce the migra-
tion of endogenous GPC6 in primary chondrocytes isolated from 
E18.5 femurs. Fig. 10 shows that, like in the case of NIH 3T3 
cells, treatment with Shh for 1 h induced a very clear migration 
of GPC6 into the cilium of chondrocytes and that its presence in 
this appendage is drastically reduced after 4 h of Shh treatment.
Discussion
In this study, we show that GPC6-null mice display signifi-
cantly shorter long bones than normal littermates. In addition, 
the mutant mice present severe facial dysmorphism. Therefore, 
these observations indicate that GPC6-null mice represent a 
good model to study the molecular basis of OMOD1. We have 
also generated a mouse strain in which GPC6 has been specifi-
Figure 5. Chondrocyte-specific GPC6-null mice display shorter long bones. (Left) Femurs and tibia from WT and GPC6-null (KO) P21 mice were dissected, 
and their lengths were measured as described in Fig. 2. A total of five WT and six KO mice originated from four different litters were studied. Scatter plots 
with the mean ± SEM are shown. Mean WT femur length in each litter was arbitrarily assigned the value of 1. (Right) RNA was extracted from the measured 
bones, and the levels of GPC6 were assessed by real time RT-PCR. Bars represent the mean + SEM. Mean value for the WT in each litter was arbitrarily 
assigned the value of 1. Statistical analysis was performed by Student’s t test (unpaired two-tailed).
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cally deleted in chondrocytes. Unlike the global KO, the chon-
drocyte-specific GPC6 mutants are viable, but they also display 
a significant shortening of the long bones. This confirms that 
GPC6 plays a direct role in bone development.
Notably, OMOD1 is the second human genetic condition 
characterized by abnormal bone development in which a mem-
ber of the GPC family has been implicated. Simpson- Golabi-
Behmel overgrowth syndrome is caused by loss-of function 
mutations in the GPC3 gene (Pilia et al., 1996). We have pre-
viously demonstrated that GPC3 acts as an inhibitor of Hh sig-
naling in the embryonic bone, and we have proposed that the 
overgrowth observed in the Simpson-Golabi-Behmel patients is 
caused, at least in part, by increased Hh activity (Capurro et al., 
2008, 2009). Interestingly, in this study, we have shown that, 
in the context of long bone development, GPC6 displays the 
opposite activity compared with GPC3: it acts to stimulate Hh 
signaling, strongly suggesting that OMOD1 is caused, at least 
in part, by reduced Hh activity in the developing long bones.
The present study provides extensive evidence that GPC6 
stimulates Hh signaling. First, we showed that the expression 
of Gli1 and Ptc1, two well-established Hh pathway targets, is 
significantly reduced in the developing femurs of GPC6-null 
mice. Second, by breeding GPC6-heterozygous mice with Ihh- 
heterozygous mice, we provided genetic evidence indicating 
that the Ihh signaling pathway mediates the regulatory activity 
of GPC6 on embryonic bone growth. Third, we demonstrated 
that GPC6 can strongly stimulate Hh signaling in luciferase 
reporter assays. Fourth, we showed that GPC6 can bind with 
high affinity to Shh and Ihh. In addition, our finding that growth 
plate chondrocytes from GPC6-null developing bones display 
reduced proliferation compared with chondrocytes from normal 
littermates is also consistent with a role of GPC6 as a positive 
regulator of Hh signaling.
GPCs have been shown to regulate canonical (β-catenin 
dependent) and noncanonical (β-catenin independent) Wnt sig-
naling. Wnt5a is a well-characterized stimulator of noncanoni-
cal Wnt signaling. Notably, Wnt5a-null mice display perinatal 
lethality, severe dwarfism, short limbs, and facial dysmorphisms 
(Yamaguchi et al., 1999). Thus, in principle, if GPC6 is a pos-
itive regulator of noncanonical Wnt signaling, it could be pro-
posed that the phenotype of the GPC6-null embryos is caused, 
at least in part, by a reduction in noncanonical Wnt signaling. 
Figure 6. GPC6 stimulates the Hh signaling 
pathway. (A) Hh reporter assay. NIH3T3 cells 
were transfected with GPC6 (left) or GPC3 
(right) or vector control (cytomegalovirus pro-
moter [pCMV] and elongation factor promoter 
[EF]) along with a luciferase reporter driven by 
an Hh-responsive promoter and β-galactosi-
dase. Transfected cells were stimulated during 
48  h with ShhN- or control-conditioned me-
dium. Then, luciferase and β-galactosidase as-
says were performed. Bars represent luciferase 
activity fold stimulation induced by Hh (mean 
+ SEM of triplicates) normalized by β-galacto-
sidase activity. One representative experiment 
of four is shown. (B) Increased binding of Shh 
to Ptc1 in the presence of GPC6. NIH3T3 cells 
expressing increasing amounts of GPC3 or 
GPC6 were incubated for 2.5 h at 4°C with 
Shh-AP or AP. Then, Ptc1 was immunoprecip-
itated, and the amount of Shh bound to the 
immunoprecipitated Ptc1 was determined by 
measuring AP activity. Bars represent the rel-
ative amount of Shh-AP bound to Ptc1 (mean 
+ SEM of four independent experiments) after 
subtraction of the binding measured for AP 
alone. Shh-AP binding to the cells transfected 
with vector control was arbitrarily considered 
1.  (C) HS chains are required for maximum 
GPC6-induced stimulation of Hh signaling. 
NIH3T3 cells were transfected with increasing 
amounts of the indicated expression vectors 
along with a luciferase reporter driven by an 
Hh-responsive promoter and β-galactosidase. 
Then, luciferase activity in the presence and 
absence of Shh was performed as described 
in A.  Bars represent luciferase activity fold 
stimulation induced by Hh (mean + SEM of 
triplicates) normalized by β-galactosidase ac-
tivity. One representative experiment of two is 
shown. *, P < 0.05; **, P < 0.005; ***, P < 
0.001. Statistical analysis was performed by 
Student’s t test (unpaired two-tailed).
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One of the well-established changes induced by Wnt5a in many 
cell types is the phosphorylation of Dvl3 and Dvl2, and Wnt5a- 
null embryos display a significant reduction in such phosphory-
lation (Ho et al., 2012). However, we did not detect any signifi-
cant difference in the degree of Dvl3 and Dvl2 phosphorylation 
in the GPC6-null femurs compared with those of the WT litter-
mates (Fig. S3). Thus, even though we cannot discard a role of 
the noncanonical Wnt pathway in the phenotype of the GPC6-
null mice, it is highly unlikely that this pathway is an important 
mediator of the regulatory activity of GPC6 in bone develop-
ment. In this regard, it should be noted that Wnt5a-null mice 
display a drastic reduction of Ihh expression in the developing 
Figure 7. GPC6 interacts with Shh, Ihh, and Ptc1. (A) SPR analysis of the interaction of Shh and Ihh with GPC6-AP and GPC6ΔGAG-AP. Purified GPC6-AP 
and GPC6ΔGAG-AP were biotinylated and then immobilized on SA sensor chips (GPC6, 1,300 relative units [RU]; GPC6ΔGAG, 700 RU). Various con-
centrations of recombinant Shh or Ihh (from 62.5 to 1,000 nM) were injected to determine the binding profile. This experiment was repeated three times, 
and the results shown represent the mean ± SEM. (B) GPC6/Ptc1 pull-down assay. The interaction between Ptc1 and GPC6-AP or GPC6ΔGAG-AP was 
determined by a pull-down assay. Beads covered by Ptc1 were incubated with GPC6-AP–, GPC6ΔGAG-AP–, or vector control–conditioned media. Bars 
represent the mean of triplicates + SD. The experiment was repeated three times with similar results. A representative experiment is shown. (C) GPC6/
Ptc1 cell-binding assay. 293T cells were transfected with a Ptc1 expression vector or vector control. Transfected cells were incubated with GPC6-AP–, 
GPC6ΔGAG-AP–, or AP-conditioned media containing equal AP concentrations for 2 h at 4°C. Cells were washed and lysed, and the AP activity of ali-
quots of cell lysates containing the same amount of protein was measured. Bars represent the mean of triplicates + SD. The experiment was repeated four 
times with similar results.
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long bones (Yang et al., 2003). Therefore, it is possible that the 
shortened bones in Wnt5a-null embryos are, at least in part, the 
indirect consequence of reduced Ihh signaling.
Our in vitro studies have shown that GPC6 stimulates 
Hh signaling by increasing the interaction of Shh with Ptc1 
(Fig. 6 B). Based on this finding and on our results indicating 
that GPC6 interacts with both Shh and Ptc1 (Fig. 7), we propose 
that GPC6 increases Hh signaling by forming a complex with 
these two proteins that facilitates/stabilizes their interaction.
We demonstrated by SPR analysis that Shh and Ihh 
can directly bind with high affinity to the GPC6 core protein 
(Fig.  7). Previously, we had shown that the core protein of 
GPC3 can also bind with high affinity to Shh and Ihh (Capurro 
et al., 2008). Likewise, it has been reported that Drosophila Hh 
directly interacts with the core protein of the GPC Dlp (Yan et 
al., 2010). However, the interaction of GPC5 with Shh is medi-
ated by the GAG chains (Li et al., 2011). The molecular basis of 
this differential interaction of the core proteins of various GPCs 
with Hhs remains to be uncovered.
We have also shown here that GPC6 can bind to Ptc1 
and that this interaction is mediated by the GAG chains. Sim-
ilar findings have been reported for GPC5 (Li et al., 2011). 
Therefore, we are proposing that GPC6 stimulates Hh signal-
ing by binding to both Hh and Ptc1 and facilitating/stabiliz-
ing their interaction. As such, it would be expected that the 
nonglycanated GPC6ΔGAG would not be able to stimulate 
Hh signaling. Experimentally, we have found that high lev-
els of expression of this mutant can exert a modest stimula-
tory effect on Hh activity (Fig. 6 C). This finding could be 
explained by the fact that Hh can bind with high affinity to 
Figure 8. Shh induces the migration of GPC6 
to the cilia. (A) NIH 3T3 cells were transfected 
with GPC6 or GPC6ΔGAG and treated with 
Shh-conditioned medium or vector control–
conditioned medium for 1 h. Then, cells were 
immunostained with antibodies for GPC6 (red) 
and acetylated tubulin (green). Boxes in the 
corners represent shifted overlays of enlarge-
ments of the indicated areas containing the 
cilia. (B) GPC6 or GPC6ΔGAG immunofluo-
rescence at the cilium of transfected NIH 3T3 
cells was measured before and after Shh treat-
ment for the indicated time periods. The fluo-
rescence intensities shown represent the mean 
of measurements performed in the follow-
ing number of cells transfected with GPC6/
GPC6ΔGAG: 30/25 (0  h), 22/11 (0.5  h), 
30/25 (1 h), 39/10 (2 h), 10/26 (4 h), and 
22/20 (8  h) ± SD. A two-tailed Student’s t 
test was applied for statistical analysis. *, P < 
0.005 (significantly different).
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the core protein of GPC6. This interaction would increase 
the concentration of Hh at the cell surface, therefore reduc-
ing the dimensionality of ligand movement and consequently 
increasing the frequency of encounters between Hh and Ptc1. 
This mechanism has been proposed to explain the stimulatory 
effects of many cell-surface proteoglycans on cell signaling 
(Schlessinger et al., 1995).
One of the most important findings of this study is that, 
whereas in the absence of Hh, GPC6 is located outside of the 
primary cilium, Hh addition results in the migration of GPC6 
to this appendage, where Hh signaling is normally triggered 
(Fig. 8). Notably, ciliary accumulation can be detected as early 
as 30 min after Hh addition, but GPC6 does not stay very long 
in the cilium, becoming almost undetectable at this location 
after 4 h. Interestingly, we also observed that, in the presence of 
Hh, GPC6 stimulates the accumulation of Smo at this organelle 
(Fig. 9). The Hh-induced migration of GPC6 into the cilium 
was observed both in GPC6-transfected embryonic fibroblasts 
(Fig. 8) and in primary chondrocytes from the femur expressing 
endogenous GPC6. The localization of GPC6 at the cilium in 
the presence of Hh is consistent with its capacity to bind to Ptc1 
and to stimulate Hh activity.
We have previously reported that GPC5 is located at the 
cilium even in the absence of exogenous Hh (Li et al., 2011). 
However, GPC3 is located outside of the cilium in the presence 
and absence of this growth factor (Li et al., 2011). Therefore, it 
seems that ciliary localization correlates with the capacity of a 
given GPC to stimulate Hh signaling.
Currently, the mechanism of Hh-induced migration to the 
cilium remains unknown. However, the fact that the nongly-
canated mutant GPC6ΔGAG does not move to the cilium in the 
presence of Hh suggests that GPC6 might piggyback through 
the GAG chains with another protein that has the capacity to 
migrate to the cilium in the presence of Hh.
Materials and methods
Mouse strains
Gpc6-heterozygous mice (B6N.129S5-Gpc6tm1/Lex/Mmcd) were ob-
tained from the Mutant Mouse Regional Resource Center at the Uni-
versity of San Diego. Ihh-heterozygous mice were purchased from the 
Jackson Laboratory. C57BL/6 WT mice were obtained from Charles 
River Canada Laboratories. All the procedures used for mouse exper-
iments were approved by the Animal Care Committee of the Sunny-
brook Research Institute.
To generate chondrocyte-specific GPC6-null mice, a mouse 
strain containing a floxed GPC6 allele was purchased from EUC OMM. 
The modified allele had two loxP sites flanking exon 3 of GPC6, as 
well as a neomycin gene and a LacZ reporter flanked by two flippase 
recognition target sites. These mice were crossed with C57BL/6N 
Flp-recombinase transgenic mice (under the control of the ActnB pro-
moter) to remove the Neo marker and LacZ reporter gene in every cell. 
The resulting mice were crossed with B6;SJL-Tg(Col2α1-Cre)1Bhr/J 
transgenic mice (purchased from Jackson laboratories) expressing the 
Cre recombinase under the control of the Col2α1 gene promoter. As the 
Col2α1 gene is expressed in chondrocytes, this crossing leads to the ex-
cision of GPC6 exon 3 specifically in these cells and, therefore, to the 
generation of a cartilage-specific GPC6-null mouse. After backcross 
on a C57BL/6N background, mice heterozygous for the GPC6 KO 
allele in chondrocytes were mated between them to obtain cartilage- 
specific GPC6-null mice.
Breeding and processing of mice
GPC6 KO and WT littermates were obtained by mating GPC6 hetero-
zygotes. Double GPC6-Ihh heterozygotes were first obtained by cross-
ing GPC6 and Ihh heterozygotes and then mated to generate the GPC6/
Ihh double-KO embryos. The body weights of E17.5–E18.5 embryos 
were obtained immediately after dissection. Then, tail tip samples 
were collected and subsequently genotyped by PCR. Whole embryos 
or dissected limbs were processed for Alcian blue–Alizarin staining. 
Tissue sections from dissected femurs were paraffin embedded for im-
munohistochemical analysis. Femoral RNA was isolated for real-time 
PCR assessment of Hh target levels. Whole-embryo histopathology 
was performed at the Centre for Modeling Human Disease, Toronto 
Centre for Phenogenomics.
Cell lines and plasmids
293T and NIH 3T3 cells (obtained from the ATCC) were cultured 
in DMEM supplemented with 10% FBS at 37°C in a humidified 
atmosphere with 5% CO2. Primary chondrocytes were gener-
Figure 9. GPC6 stimulates the migration of Smo to the cilia after Shh treat-
ment. (A) NIH 3T3 cells were transfected with GPC6, GPC6ΔGAG, or vec-
tor control. Transfected cells were treated with Shh for the indicated time 
periods, and cells were stained with antibodies against Smo and acetylated 
tubulin. The fluorescence intensities shown represent the mean of measure-
ments performed in the following number of cells transfected with vector/
GPC6/GPC6ΔGAG: 23/29/23 (0 h), 27/26/19 (1 h), 26/26/28 (2 h), 
and 26/37/22 (4 h) ± SD. *, P < 0.01 (significantly different). (B) NIH 3T3 
cells were transfected with GPC6 or GPC6ΔGAG. Transfected cells were 
treated with SAG for the indicated time periods, and cells were stained with 
antibodies against GPC6 and acetylated tubulin. The fluorescence intensi-
ties shown represent the mean of measurements performed in the following 
number of cells transfected with GPC6/GPC6ΔGAG: 9/7 (0  h), 15/15 
(0.5 h), 11/11 (2 h), and 10/10 (4 h) ± SD. Two-tailed Student’s t tests were 
applied for statistical analysis.
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ated from mouse embryos as previously described (Gosset et al., 
2008) and cultured in DMEM supplemented with 10% FBS and 
2  mM glutamine. Expression vectors for GPC6, GPC6ΔGAG, 
GPC3, GPC3ΔGAG, GPC6-AP, GPC6ΔGAG-AP, fully processed 
Shh, ShhN, AP, Shh-AP, and Ptc-HA were previously described 
(Capurro et al., 2008, 2014).
Analysis of BrdU incorporation
15.5-d pregnant mice were injected intraperitoneally 1 h before sac-
rifice with 400 µl of the BrdU labeling reagent (BrdU Labeling and 
Detection kit II; Roche). Embryonic femurs were dissected, fixed in 
10% formalin overnight, and stored in 70% ethanol until processing. 
Paraffin-embedded sections were prepared, and BrdU staining was 
performed with an anti-BrdU mouse monoclonal antibody (clone 
BMG6H8; Roche), and a Mouse on Mouse (M.O.M.) Immunode-
tection kit (VEC TOR Laboratories). Tissue sections were blocked in 
M.O.M. blocking reagent and then were incubated with an anti-BrdU 
antibody (1:10 in M.O.M. diluents) overnight at 4°C. After washing 
twice with PBS, a biotinylated anti–mouse IgG antibody was added for 
10 min. Bound antibody was detected with Vectastain ABC and DAB. 
For quantification of BrdU labeling, all the BrdU-positive and -negative 
nuclei in each femur section were counted.
Quantification of Ptc1 and Gli1 transcripts
E15.5 femurs were dissected, and RNA was extracted using TRIzol 
reagent (Invitrogen). cDNA was generated by reverse transcription 
using oligo(dT)12–18 primers (Invitrogen). The relative levels of Ptc1 
and Gli1 transcripts were measured by real-time RT-PCR, using β- 
Figure 10. Shh induces the migration of GPC6 in primary chondrocytes. (A) Chondrocytes isolated from E18.5 femurs were treated with Shh- or vector 
control–conditioned medium for 1 h. Then, cells were immunostained with antibodies for GPC6 (red) and acetylated tubulin (green). Boxes in the corners 
represent shifted overlays of enlargements of the indicated areas containing the cilium (bars, 1 µm). (B) GPC6 fluorescence at the cilia of chondrocytes was 
measured before and after Shh treatment for the indicated time points. The fluorescence intensities shown represent the mean of measurements performed 
in the following number of cells: 28 (0 h), 27 (1 h), 12 (2 h), and 12 (4 h) ± SD.
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actin transcript levels as standards. A sequence detection system (ABI 
Prism 7000; Applied Biosystems) and QuantiTect SYBR Green (Qia-
gen) were used. Sequence of the oligonucleotide primers used were: 
Gli1 forward (F), 5′-AGG GAG GAA AGC AGA CTG AC-3′ and reverse 
(R), 5′-CCA GTC ATT TCC ACA CCA CT-3′; Ptc1 F, 5′-CAA GTG TCG 
TCC GGT TTGC-3′ and R, 5′-CTG TAC TCC GAG TCG GAG GAA-
3′; and β-actin F, 5′-TTC TAC AAT GAG CTG CGT GTG-3′ and R, 5′-
GGG GTG TTG AAG GTC TCA AA-3′.
Immunohistochemistry
Embryonic femurs were dissected, fixed in 10% formalin overnight, 
and stored in 70% ethanol until processing. Paraffin-embedded 
femur growth plate sections were prepared from E15.5 embryos. 
Ihh, Ki67, and Cyclin D1 were immunostained with antibodies 
from Santa Cruz (sc-1196; 1:75), Cell Signaling (no. 12202; 1:400), 
and Abcam (ab134175; 1:200), respectively. DAB was used as a 
color-developing agent.
Hh reporter assay
NIH 3T3 cells were seeded in 6-well plates (220,000 cells/well) and 
transfected with an Hh-luciferase reporter, a β-galactosidase plasmid, 
and the indicated expression vectors. 1 d after transfection, cells were 
transferred to 24-well plates at 50% confluence, and in the next day, 
Shh-, ShhN-, or control-conditioned medium was added for 48 h. Then, 
cells were lysed, and luciferase activity was measured. This measure-
ment was normalized by the corresponding β-galactosidase activity. 
The Shh-, ShhN-, and control-conditioned media containing 2% FBS 
were prepared by transfecting 293T cells with SHH or ShhN expres-
sion vectors or vector control, respectively. The media were collected 
4 d after transfection.
Shh-Ptc1 binding assay
NIH 3T3 cells were transiently transfected with increasing amounts 
of GPC6, GPC3, or vector control. 2 d later, the transfected cells were 
incubated for 2.5 h at 4°C with conditioned medium containing a 
Shh-AP fusion protein or AP alone. After washing, cells were lysed, 
and the endogenous Ptc1 was immunoprecipitated. Then, the AP ac-
tivity in the immunoprecipitate was measured with a p-Nitrophenyl 
phosphate tablet set (SIG MAF AST; Sigma-Aldrich). The AP activity 
of immunoprecipitates from cells incubated with AP alone were sub-
tracted from each sample.
SPR analysis
This analysis was performed as previously described with a Biacore 
T200 system (GE Healthcare; Li et al., 2011). In brief, GPC6-AP 
and GPC6ΔGAG-AP fusion proteins were purified from conditioned 
medium generated by 293T cells transfected with the corresponding 
expression vectors. The purification consisted of an anion-exchange 
chromatography followed by an anti-AP affinity chromatography. 
Purified GPCs were biotinylated with EZ-link Sulfo-NHS-LC biotin 
(Thermo Fisher Scientific) and were then immobilized on streptavi-
din (SA) sensor chips (1,300 and 800 response units for GPC6-AP 
and GPC6ΔGAG-AP, respectively). Various concentrations (from 
62.5 to 1,000 nM) of recombinant Shh or Ihh were injected to de-
termine the binding profile. The flow rate was 30 µl/min. To control 
for nonspecific association of Shh or Ihh with the SA sensor chip, 
solutions of analyte were injected over the ligand-free surface and 
subtracted from binding data before analysis. All measurements 
were performed in triplicate. Sensorgrams were analyzed using 
the 1:1 ligand model provided in the BIAevaluation software (GE 
Healthcare) to calculate association and dissociation rate constants 
(ka and kd, respectively).
Pull-down assay
293T cells were transfected with an HA-tagged Ptc1 expression 
vector. 2 d after transfection, cells were lysed, and the lysates were 
incubated with an anti-HA monoclonal antibody (12CA5; Roche) 
that was attached to protein G–sepharose beads (Sigma-Aldrich). 
Then, the Ptc1-covered beads were blocked with 5% BSA in PBS 
containing 0.1% Triton X-100 for 90 min at room temperature, and 
aliquots containing equal amounts of beads were incubated for 1 h 
at room temperature with GPC6-AP, GPC6ΔGAG-AP, or AP con-
trol-conditioned media. After four washes with 20 mM Hepes, pH 
7.4, 150 mM NaCl, and 0.25% Tween 20, the AP activity bound to 
the beads was measured with a p-Nitrophenyl phosphate tablet set 
(SIG MAF AST). The background binding was measured by incubat-
ing the beads with lysates of 293T cells transfected with an AP vec-
tor control, and it was subtracted from each sample measurement. 
The GPC-AP media were generated by transfecting 293T cells with 
GPC6-AP or GPC6ΔGAG-AP expression vectors.
GPC6-Ptc1 binding assay
293T cells were plated on 24-well plates and transfected with a Ptc1 
expression vector or vector control (pcDNA). Transfected cells were 
incubated with GPC6-AP–, GPC6ΔGAG-AP–, or AP-conditioned 
media containing equal AP concentrations for 2 h at 4°C. Cells were 
extensively washed with PBS and lysed in 1% Triton and 10 mM Tris, 
pH 8.0, at room temperature for 5 min, and the AP activity of aliquots 
of cell lysates containing the same amount of protein was measured. 
GPC6-AP–, GPC6ΔGAG-AP–, or AP-conditioned media were gen-
erated by transfecting 293T cells with the corresponding expression 
vectors. 16 h after transfection, conditioned media were collected for 
24 h in medium with 10% FCS.
Localization of GPC6, GPC6ΔGAG, and Smo
NIH 3T3 cells were transfected with the indicated expression vec-
tors using Lipofectamine 3000 (InvitroGen). 1 d later, cells were 
split and plated on poly-l-lysine–treated coverslips. Then, the cells 
were starved in serum-free medium overnight, and Shh-conditioned 
media was added for the indicated time periods. Then, cells were 
incubated at 37°C in a humidified atmosphere with 5% CO2. After 
washing three times with PBS, cells were fixed with 4% parafor-
maldehyde in PBS for 10 min at 4°C. Fixed cells were blocked for 
30 min with 2% BSA in PBS, and immunofluorescence analysis 
was performed. For GPC6 detection, cells were incubated with an 
anti-GPC6 antibody (AF2845; 1:500; R&D). After washing three 
times with PBS, Alexa Fluor–coupled secondary antibodies were 
added. Then, the cells were washed and permeabilized with 0.1% 
Triton X-100 in PBS for 10 min and blocked for 30 min in 2% 
BSA. Primary cilia were visualized with anti–acetylated tubulin 
mAb (T7451; 1:1,000; Sigma-Aldrich). Smo was visualized with 
anti-HA rabbit mAb (C29F4; Cell Signaling) or anti-Smo (ab38686; 
1:1,000; Abcam). After washing three times with PBS, Alexa Fluor–
coupled secondary antibodies were added in blocking solution at 
1:1,000 dilution for 1 h at room temperature. Confocal images were 
generated using spinning-disk microscopy and a Zeiss LSM image 
browser. All images were taken with equivalent exposure time. 
Image analysis was performed using the Zen 2 program (blue edi-
tion). In brief, a mask, which was constructed by manually outlin-
ing cilia in the image of acetylated tubulin staining, was applied to 
GPC6 or Smo-stained images to measure fluorescence intensity at 
cilia. The background, which was subtracted from the fluorescence 
intensity in the cilia, was obtained by measuring several represen-
tative regions on the cell by moving the mask. For the localization 
of endogenous GPC6 in primary chondrocytes, only freshly derived 
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cells were used (P1). Cells were starved in serum-free medium 
overnight before staining.
Online supplemental material
Fig. S1 shows Western Blot analysis of Ihh in E17.5 femurs. Fig. S2 
shows an Hh reporter assay. Fig. S3 shows that Wnt signaling is not 
altered in GPC6-null femurs.
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